These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

443 related articles for article (PubMed ID: 28753780)

  • 61. Postoperative surveillance for renal cell carcinoma: a multifactorial histological subtype specific protocol.
    Siddiqui SA; Frank I; Cheville JC; Lohse CM; Leibovich BC; Blute ML
    BJU Int; 2009 Sep; 104(6):778-85. PubMed ID: 19338559
    [TBL] [Abstract][Full Text] [Related]  

  • 62. Comparison of partial nephrectomy and percutaneous ablation for cT1 renal masses.
    Thompson RH; Atwell T; Schmit G; Lohse CM; Kurup AN; Weisbrod A; Psutka SP; Stewart SB; Callstrom MR; Cheville JC; Boorjian SA; Leibovich BC
    Eur Urol; 2015 Feb; 67(2):252-9. PubMed ID: 25108580
    [TBL] [Abstract][Full Text] [Related]  

  • 63. Renal cell carcinoma with renal vein and inferior vena caval involvement: clinicopathological features, surgical techniques and outcomes.
    Parekh DJ; Cookson MS; Chapman W; Harrell F; Wells N; Chang SS; Smith JA
    J Urol; 2005 Jun; 173(6):1897-902. PubMed ID: 15879771
    [TBL] [Abstract][Full Text] [Related]  

  • 64. The outcome of patients treated with sunitinib prior to planned nephrectomy in metastatic clear cell renal cancer.
    Powles T; Blank C; Chowdhury S; Horenblas S; Peters J; Shamash J; Sarwar N; Boleti E; Sahdev A; O'Brien T; Berney D; Beltran L; Nathan P; Haanen J; Bex A
    Eur Urol; 2011 Sep; 60(3):448-54. PubMed ID: 21612860
    [TBL] [Abstract][Full Text] [Related]  

  • 65. [Partial nephrectomy for renal cell carcinoma using a microwave tissue coagulator--postoperative recurrence and renal function].
    Fujimoto K; Tanaka N; Hirao Y
    Hinyokika Kiyo; 2005 Aug; 51(8):511-5. PubMed ID: 16164265
    [TBL] [Abstract][Full Text] [Related]  

  • 66. Oncologic outcomes of patients with positive surgical margin after partial nephrectomy: a 25-year single institution experience.
    Petros FG; Metcalfe MJ; Yu KJ; Keskin SK; Fellman BM; Chang CM; Gu C; Tamboli P; Matin SF; Karam JA; Wood CG
    World J Urol; 2018 Jul; 36(7):1093-1101. PubMed ID: 29488096
    [TBL] [Abstract][Full Text] [Related]  

  • 67. Laparoscopic resection of local recurrence after previous radical nephrectomy for clinically localized renal-cell carcinoma: perioperative outcomes and initial observations.
    Yohannan J; Feng T; Berkowitz J; Connolly SS; Pierorazio P; Allaf ME
    J Endourol; 2010 Oct; 24(10):1609-12. PubMed ID: 20629564
    [TBL] [Abstract][Full Text] [Related]  

  • 68. A review of integrated staging systems for renal cell carcinoma.
    Meskawi M; Sun M; Trinh QD; Bianchi M; Hansen J; Tian Z; Rink M; Ismail S; Shariat SF; Montorsi F; Perrotte P; Karakiewicz PI
    Eur Urol; 2012 Aug; 62(2):303-14. PubMed ID: 22575911
    [TBL] [Abstract][Full Text] [Related]  

  • 69. Percutaneous radiofrequency ablation for renal cell carcinoma vs. partial nephrectomy: Comparison of long-term oncologic outcomes in both clear cell and non-clear cell of the most common subtype.
    Liu N; Huang D; Cheng X; Chong Y; Wang W; Gan W; Guo H
    Urol Oncol; 2017 Aug; 35(8):530.e1-530.e6. PubMed ID: 28408296
    [TBL] [Abstract][Full Text] [Related]  

  • 70. Renal Cell Carcinoma with Isolated Lymph Node Involvement: Long-term Natural History and Predictors of Oncologic Outcomes Following Surgical Resection.
    Gershman B; Moreira DM; Thompson RH; Boorjian SA; Lohse CM; Costello BA; Cheville JC; Leibovich BC
    Eur Urol; 2017 Aug; 72(2):300-306. PubMed ID: 28094055
    [TBL] [Abstract][Full Text] [Related]  

  • 71. Comprehensive long-term assessment of outcomes following robot-assisted partial nephrectomy for renal cell carcinoma: the ROMe's achievement and its predicting nomogram.
    Brassetti A; Anceschi U; Bertolo R; Ferriero M; Tuderti G; Costantini M; Capitanio U; Larcher A; Antonelli A; Mottrie A; Minervini A; Dell'oglio P; Veccia A; Amparore D; Flammia RS; Lombardo R; De Nunzio C; Benecchi L; Mari A; Porpiglia F; Montorsi F; Kaouk J; Autorino R; Gallucci M; Simone G
    Minerva Urol Nefrol; 2020 Aug; 72(4):482-489. PubMed ID: 32298069
    [TBL] [Abstract][Full Text] [Related]  

  • 72. CT features based preoperative predictors of aggressive pathology for clinical T1 solid renal cell carcinoma and the development of nomogram model.
    Wang K; Dong L; Li S; Liu Y; Niu Y; Li G
    BMC Cancer; 2024 Jan; 24(1):148. PubMed ID: 38291357
    [TBL] [Abstract][Full Text] [Related]  

  • 73. Outcomes following partial nephrectomy by tumor size.
    Crispen PL; Boorjian SA; Lohse CM; Sebo TS; Cheville JC; Blute ML; Leibovich BC
    J Urol; 2008 Nov; 180(5):1912-7. PubMed ID: 18801543
    [TBL] [Abstract][Full Text] [Related]  

  • 74. Plasma Glycosaminoglycans as Diagnostic and Prognostic Biomarkers in Surgically Treated Renal Cell Carcinoma.
    Gatto F; Blum KA; Hosseini SS; Ghanaat M; Kashan M; Maccari F; Galeotti F; Hsieh JJ; Volpi N; Hakimi AA; Nielsen J
    Eur Urol Oncol; 2018 Oct; 1(5):364-377. PubMed ID: 31158075
    [TBL] [Abstract][Full Text] [Related]  

  • 75. Matched comparison of radical nephrectomy vs nephron-sparing surgery in patients with unilateral renal cell carcinoma and a normal contralateral kidney.
    Lau WK; Blute ML; Weaver AL; Torres VE; Zincke H
    Mayo Clin Proc; 2000 Dec; 75(12):1236-42. PubMed ID: 11126830
    [TBL] [Abstract][Full Text] [Related]  

  • 76. Positive surgical margin following radical nephrectomy is an independent predictor of local recurrence and disease-specific survival.
    Abu-Ghanem Y; Ramon J; Berger R; Kaver I; Fridman E; Leibowitz-Amit R; Dotan ZA
    World J Surg Oncol; 2017 Nov; 15(1):193. PubMed ID: 29096642
    [TBL] [Abstract][Full Text] [Related]  

  • 77. A novel preoperative model to predict 90-day surgical mortality in patients considered for renal cell carcinoma surgery.
    Calaway AC; Monn MF; Bahler CD; Cary C; Boris RS
    Urol Oncol; 2018 Oct; 36(10):470.e11-470.e17. PubMed ID: 30274725
    [TBL] [Abstract][Full Text] [Related]  

  • 78. Conditional survival predictions after nephrectomy for renal cell carcinoma.
    Karakiewicz PI; Suardi N; Capitanio U; Isbarn H; Jeldres C; Perrotte P; Sun M; Ficarra V; Zigeuner R; Tostain J; Mejean A; Cindolo L; Pantuck AJ; Belldegrun AS; Zini L; de la Taille A; Chautard D; Descotes JL; Shariat SF; Valeri A; Mulders PF; Lang H; Lechevallier E; Patard JJ
    J Urol; 2009 Dec; 182(6):2607-12. PubMed ID: 19836798
    [TBL] [Abstract][Full Text] [Related]  

  • 79. Radical Versus Partial Nephrectomy for cT1 Renal Cell Carcinoma.
    Gershman B; Thompson RH; Boorjian SA; Lohse CM; Costello BA; Cheville JC; Leibovich BC
    Eur Urol; 2018 Dec; 74(6):825-832. PubMed ID: 30262341
    [TBL] [Abstract][Full Text] [Related]  

  • 80. Renal fossa recurrence after radical nephrectomy: Current management, and oncological outcomes.
    Romeo A; Garcia Marchiñena P; Jurado AM; Gueglio G
    Urol Oncol; 2020 Feb; 38(2):42.e7-42.e12. PubMed ID: 31711833
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 23.